Drug Profile
Glomosporin
Latest Information Update: 04 Apr 2007
Price :
$50
*
At a glance
- Originator Kaken Pharmaceutical
- Class Antifungals; Depsipeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 04 Apr 2007 Discontinued - Preclinical for Mycoses in Japan (unspecified route)
- 22 Aug 2000 Preclinical development for Mycoses in Japan (unspecified route)